Childhood Cancer Therapeutic Catalyst

The Childhood Cancer Therapeutic Catalyst is a grant scheme that accelerates translation of discovery research into novel therapeutics for children and young people with cancer. Funded projects run collaboratively between academic groups and Cancer Research Horizons drug discovery laboratories and are awarded by Cancer Research UK. Projects are typically short-term (up to 18 months) and aim to de-risk early drug discovery to facilitate further funding, partnering or development.

Up to £250K per project; up to 18 months of funding; assignment of a Therapeutic Innovation scientist to support proposal development and regular project catch-up meetings; access to Cancer Research Horizons drug discovery laboratory support and potential routes to accelerate toward patient benefit (including C-Further).

Academic researchers based at any university or research institute worldwide with their own lab and/or performing independent research may apply. The scheme is open to global applications.

Two-stage application: submit an expression of interest for internal triage; if successful you will be invited to submit a full project proposal and collaborate with an assigned Therapeutic Innovation scientist to prepare the costed proposal.